Mankind Pharma Limited has incorporated a wholly owned subsidiary company in the Netherlands under the name "Mankind Pharma (Netherlands) B.V." on August 13, 2026. This incorporation follows the company's earlier intimation dated July 11, 2026 regarding the proposed subsidiary.
The disclosure is made pursuant to Regulations 30 and 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").
The company confirms that detailed disclosures as required under the Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were already provided in the company's intimation dated July 11, 2026.
The document was signed by Hitesh Kumar Jain, Company Secretary & Compliance Officer, on August 13, 2026 at 21:19:02 IST.
Financial Impact
Financial impact not quantified in the disclosure.